Sustainable production for plant derived pharmaceutical and nutritional products from Hypoxia tuber, phase I

The production of Hypoxis-derived pharmaceutical and nutritional formulations is necessary to support the country's efforts in providing nutritional food to HIV/AIDS infected/affected persons.
This project aims to establish a Hypoxis cloning/multiplication unit at INIA laboratory to guarantee the continuous supply of products containing the Hypoxis tuber. The project will also strengthen the existing industrial facilities to enable the development of formulation technologies.